PNEUMOCYSTIS JIROVECII INFECTION
Clinical trials for PNEUMOCYSTIS JIROVECII INFECTION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECII INFECTION trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECII INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study seeks best backup plan for deadly pneumonia in immunocompromised patients
Disease control Not yet recruitingThis study looks at which second-choice treatment works best for a serious lung infection called PCP when the usual antibiotic cannot be used due to allergies, side effects, or failure. About 416 adults with weakened immune systems (from HIV, transplants, cancer, or other causes)…
Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Shorter steroid course for severe PCP? new trial aims to find out
Disease control Not yet recruitingThis study looks at how long steroids should be given to adults with severe Pneumocystis pneumonia (PCP), a serious lung infection common in people with weakened immune systems. About 416 participants who improve within 10 days will either stop steroids early or continue for 21 d…
Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC